{"data":{"id":3995,"citation":"Matheson CJ, Coxon CR, Bayliss R, Boxall K, Carbain B, Fry AM, Hardcastle IR, Harnor SJ, Mas-Droux C, Newell DR, Richards MW, Sivaprakasam M, Turner D, Griffin RJ, Golding BT, Cano C.: 2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase. RSC Med Chem, Volume 11 (6), 2020","title":"2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase.","doi":"10.1039\/d0md00074d","doi_url":"https:\/\/doi.org\/10.1039\/d0md00074d","pmid":"33479670","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/33479670\/","year":2020,"journal":"RSC Med Chem","volume":"11","issue":"6","page":"707-731","authors":[{"first_name":"Bayliss R","last_name":null,"full_name":null},{"first_name":"Boxall K","last_name":null,"full_name":null},{"first_name":"Cano C.","last_name":null,"full_name":null},{"first_name":"Carbain B","last_name":null,"full_name":null},{"first_name":"Coxon CR","last_name":null,"full_name":null},{"first_name":"Fry AM","last_name":null,"full_name":null},{"first_name":"Golding BT","last_name":null,"full_name":null},{"first_name":"Griffin RJ","last_name":null,"full_name":null},{"first_name":"Hardcastle IR","last_name":null,"full_name":null},{"first_name":"Harnor SJ","last_name":null,"full_name":null},{"first_name":"Mas-Droux C","last_name":null,"full_name":null},{"first_name":"Matheson CJ","last_name":null,"full_name":null},{"first_name":"Newell DR","last_name":null,"full_name":null},{"first_name":"Richards MW","last_name":null,"full_name":null},{"first_name":"Sivaprakasam M","last_name":null,"full_name":null},{"first_name":"Turner D","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/3995","landing_page":"https:\/\/molmedb.upol.cz\/publication\/3995","created_at":"2024-05-21T20:14:29.000000Z","updated_at":null}}